scispace - formally typeset
K

Kausik Bishayee

Researcher at Hallym University

Publications -  40
Citations -  986

Kausik Bishayee is an academic researcher from Hallym University. The author has contributed to research in topics: Apoptosis & Cancer cell. The author has an hindex of 18, co-authored 30 publications receiving 794 citations. Previous affiliations of Kausik Bishayee include Kalyani Government Engineering College & Zhejiang Chinese Medical University.

Papers
More filters
Journal ArticleDOI

Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction.

TL;DR: One dietary flavonoid, quercetin (found in many fruit and vegetables), is examined for possible anti‐cancer effects, on HeLa cells originally derived from a case of human cervical cancer.
Journal ArticleDOI

[6]-Gingerol induces caspase 3 dependent apoptosis and autophagy in cancer cells: drug-DNA interaction and expression of certain signal genes in HeLa cells.

TL;DR: Overall results suggest that [6]-gingerol has potential to bind with DNA and induce cell death by autophagy and caspase 3 mediated apoptosis.
Journal ArticleDOI

PLGA-Loaded Gold-Nanoparticles Precipitated with Quercetin Downregulate HDAC-Akt Activities Controlling Proliferation and Activate p53-ROS Crosstalk to Induce Apoptosis in Hepatocarcinoma Cells.

TL;DR: It is determined by circular dichroism spectroscopy that NQ effectively caused conformational changes in DNA and modulated different proteins related to epigenetic modifications and cell cycle control to acquire the sustained release property.
Journal ArticleDOI

5-Lipoxygenase Antagonist therapy: a new approach towards targeted cancer chemotherapy

TL;DR: Evidence is accumulating in support of the direct involvement of 5-LOX in the progression of different types of cancer including prostate, lung, colon, and colorectal cancers and studies of these well-characterized agents are warranted for their use as possible candidates for chemotherapeutic studies against the killer disease cancer.